Combatting bacterial persister cells

Biotechnology and Bioengineering

Volumn 113, Issue 3, 2016, Pages 476-483

  Wood, Thomas K ^a,b  

^a The Pennsylvania State University   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial tolerance; Cell signaling; Persister cells

Indexed keywords

ANTIBIOTICS; BALLOONS; BIOFILMS; CELLS; CYTOLOGY; GENES;

BACTERIAL CELLS; ENVIRONMENTAL STRESS; GENETIC PATHWAYS; PERSISTER CELLS; RESTING STATE;

CELL SIGNALING;

ANTIBIOTIC AGENT; ANTITOXIN; BACTERIAL TOXIN; INDOLE; ANTIINFECTIVE AGENT;

BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL INFECTION; BACTERIAL PERSISTER CELL; GENETIC ANALYSIS; HUMAN; INFECTION CONTROL; INTRACELLULAR SIGNALING; MICROBIAL ACTIVITY; NONHUMAN; REVIEW; STRESS; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL VIABILITY; SIGNAL TRANSDUCTION;

EID: 84955643490     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.25721     Document Type: Review

References (90)

1. Allen RC, Popat R, Diggle SP, Brown SP. 2014. Targeting virulence: Can we make evolution-proof drugs? Nat Rev Micro 12:300-308.
2. Allison KR, Brynildsen MP, Collins JJ. 2011. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-220.
3. Amato SM, Orman MA, Brynildsen MP. 2013. Metabolic control of persister formation in Escherichia coli. Mol Cell 50:475-487.
4. Ayrapetyan M, Williams TC, Oliver JD. 2015. Bridging the gap between viable but non-culturable and antibiotic persistent bacteria. Trends Microbiol 23:7-13.
5. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
6. Bansal T, Alaniz RC, Wood TK, Jayaraman A. 2010. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 107:228-233.
7. Bigger JW. 1944. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244:497-500.
8. Bradner WT. 2001. Mitomycin C: A clinical update. Cancer Treat Rev 27:35-50.
9. Brown BL, Grigoriu S, Kim Y, Arruda JM, Davenport A, Wood TK, Peti W, Page R. 2009. Three dimensional structure of the MqsR:MqsA complex: A novel toxin:antitoxin pair comprised of a toxin homologous to RelE and an antitoxin with unique properties. PLoS Pathog 5:e1000706.
10. Chan WT, Balsa D, Espinosa M. 2015. One cannot rule them all: Are bacterial toxins-antitoxins druggable? FEMS Microbiol Rev 39:522-540.
11. Chen X, Zhang M, Zhou C, Kallenbach NR, Ren D. 2011. Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol 77:4878-4885.
12. Cheng H-Y, Soo VWC, Islam S, McAnulty MJ, Benedik MJ, Wood TK. 2014. Toxin GhoT of the GhoT/GhoS toxin/antitoxin system damages the cell membrane to reduce adenosine triphosphate and to reduce growth under stress. Environ Microbiol 16:1741-1754.
13. Chu W, Zere TR, Weber MM, Wood TK, Whiteley M, Hidalgo-Romano B, Valenzuela E, McLean RJC. 2012. Indole production promotes Escherichia coli mixed-culture growth with Pseudomonas aeruginosa by inhibiting quorum signaling. Appl Environ Microbiol 78:411-419.
14. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, Leonard SN, Smith RD, Adkins JN, Lewis K. 2013. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503:365-370.
15. Davies DG, Marques CNH. 2009. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 191:1393-1403.
16. Domka J, Lee J, Wood TK. 2006. YliH (BssR) and YceP (BssS) regulate Escherichia coli K-12 biofilm formation by influencing cell signaling. Appl Environ Microbiol 72:2449-2459.
17. Domka J, Lee J, Bansal T, Wood TK. 2007. Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol 9:332-346.
18. Dörr T, Vulić M, Lewis K. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8:e1000317.
19. Feng J, Auwaerter PG, Zhang Y. 2015. Drug Combinations against Borrelia burgdorferi persisters in vitro: Eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS ONE 10:e0117207.
20. García-Contreras R, Maeda T, Wood TK. 2013a. Resistance to Quorum Quenching Compounds. Appl Environ Microbiol 79:6840-6846.
21. García-Contreras R, Martínez-Vázquez M, Velázquez-Guadarrama N, Villegas Pañeda AG, Hashimoto T, Maeda T, Quezada H, Wood TK. 2013b. Resistance to the quorum-quenching compounds brominated furanone C-30 and 5-fluorouracil in Pseudomonas aeruginosa clinical isolates. Pathog Dis 68:8-11.
22. García-Contreras R, Maeda T, Wood TK. 2015a. Can resistance against quorum-sensing interference be selected? ISME J on-line: doi:10.1038/ismej.2015.84.
23. García-Contreras R, Nuñez-López L, Jasso-Chávez R, Kwan BW, Belmont JA, Rangel-Vega A, Maeda T, Wood TK. 2015b. Quorum sensing enhancement of the stress response promotes resistance to quorum quenching and prevents social cheating. ISME J 9:115-125.
24. Gerdt JP, Blackwell HE. 2014. Competition studies confirm two major barriers that can preclude the spread of resistance to quorum-sensing inhibitors in bacteria. ACS Chem Biol 9:2291-2299.
25. Germain E, Castro-Roa D, Zenkin N, Gerdes K. 2013. Molecular mechanism of bacterial persistence by HipA. Mol Cell 52:248-254.
26. González Barrio AF, Zuo R, Hashimoto Y, Yang L, Bentley WE, Wood TK. 2006. Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J Bacteriol 188:305-316.
27. Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, Turner RJ, Ceri H. 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 53:2253-2258.
28. Hazan R, Engelberg-Kulka H. 2004. Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P 1. Mol Genet Genomics 272:227-234.
29. Hidalgo-Romano B, Gollihar J, Brown SA, Whiteley M, Valenzuela E, Kaplan HB, Wood TK, McLean RJC. 2014. Indole inhibition of N-acylated homoserine lactone-mediated quorum signalling is widespread in Gram-negative bacteria. Microbiology 160:2464-2473.
30. Hirakawa H, Inazumi Y, Masaki T, Hirata T, Yamaguchi A. 2005. Indole induces the expression of multidrug exporter genes in Escherichia coli. Mol Microbiol 55:1113-1126.
31. Hobby GL, Meyer K, Chaffee E. 1942. Observations on the mechanism of action of penicillin. Proc Soc Exp Biol Med 50:281-285.
32. Hong SH, Wang X, O'Connor HF, Benedik MJ, Wood TK. 2012. Bacterial persistence increases as environmental fitness decreases. Microb Biotechnol 5:509-522.
33. Hu Y, Benedik MJ, Wood TK. 2012. Antitoxin DinJ influences the general stress response through transcript stabilizer CspE. Environ Microbiol 14:669-679.
34. Hu Y, Kwan BW, Osbourne DO, Benedik MJ, Wood TK. 2015. Toxin YafQ increases persister cell formation by reducing indole signalling. Environ Microbiol 17:1275-1285.
35. Islam S, Benedik MJ, Wood TK. 2015. Orphan Toxin OrtT (YdcX) of Escherichia coli Reduces Growth during the Stringent Response. Toxins 7:299-321.
36. Izadpanah A, Gallo RL. 2005. Antimicrobial peptides. J Am Acad Dermatol 52:381-390.
37. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004a. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230:13-18.
38. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004b. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186:8172-8180.
39. Kim JS, Heo P, Yang TJ, Lee KS, Cho DH, Kim BT, Suh JH, Lim HJ, Shin D, Kim SK, Kweon DH. 2011. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother 55:5380-5383.
40. Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM, Mylonakis E. 2015. Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy. PLoS ONE 10:e0127640.
41. Kim Y, Wood TK. 2010. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem Biophys Res Commun 391:209-213.
42. Kobayashi A, Hirakawa H, Hirata T, Nishino K, Yamaguchi A. 2006. Growth phase-dependent expression of drug exporters in Escherichia coli and its contribution to drug tolerance. J Bacteriol 188:5693-5703.
43. Korch SB, Henderson TA, Hill TM. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p) ppGpp synthesis. Mol Microbiol 50:1199-1213.
44. Kwan BW, Chowdhury N, Wood TK. 2015a. Combatting bacterial infections by killing persister cells with mitomycin C. Environ Microbiol on line: doi: 10.1111/1462-2920.12873.
45. Kwan BW, Lord DM, Peti W, Page R, Benedik MJ, Wood TK. 2015b. The MqsR/MqsA toxin/antitoxin system protects Escherichia coli during bile acid stress. Environ Microbiol on-line doi: 10.1111/1462-2920.12749.
46. Kwan BW, Osbourne DO, Hu Y, Benedik MJ, Wood TK. 2015c. Phosphodiesterase DosP increases persistence by reducing cAMP which reduces the signal indole. Biotechnol Bioeng 112:588-600.
47. Kwan BW, Valenta JA, Benedik MJ, Wood TK. 2013. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother 57:1468-1473.
48. Lee J, Bansal T, Jayaraman A, Bentley WE, Wood TK. 2007a. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl Environ Microbiol 73:4100-4109.
49. Lee J, Jayaraman A, Wood TK. 2007b. Indole is an inter-species biofilm signal mediated by SdiA. BMC Microbiol 7:42.
50. Lee J, Zhang X-S, Hegde M, Bentley WE, Jayaraman A, Wood TK. 2008. Indole cell signaling occurs primarily at low temperatures in Escherichia coli. ISME J 2:1007-1023.
51. Lee J, Attila C, Cirillo SL, Cirillo JD, Wood TK. 2009a. Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence. Microb Biotechnol 2:75-90.
52. Lee J, Maeda T, Hong SH, Wood TK. 2009b. Reconfiguring the quorum-sensing regulator SdiA of Escherichia coli to control biofilm formation via indole and N-acylhomoserine lactones. Appl Environ Microbiol 75:1703-1716.
53. Lee HH, Molla MN, Cantor CR, Collins JJ. 2010. Bacterial charity work leads to population-wide resistance. Nature 467:82-85.
54. Lewis K. 2007. Persister cells, dormancy and infectious disease. Nat Rev Micro 5:48-56.
55. Lewis K. 2008. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322:107-131.
56. Lewis K. 2010. Persister cells. Annu Rev Microbiol 64:357-372.
57. Luidalepp H, Jõers A, Kaldalu N, Tenson T. 2011. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. J Bacteriol 193:3598-3605.
58. Maeda T, García-Contreras R, Pu M, Sheng L, Garcia LR, Tomás M, Wood TK. 2012. Quorum quenching quandary: Resistance to antivirulence compounds. ISME J 6:493-501.
59. Maisonneuve E, Shakespeare LJ, Jørgensen MG, Gerdes K. 2011. Bacterial persistence by RNA endonucleases. P Natl Acad Sci USA 108:13206-13211.
60. Maisonneuve E, Castro-Camargo M, Gerdes K. 2013. (p) ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 154:1140-1150.
61. Marques CNH, Morozov A, Planzos P, Zelaya HM. 2014. The fatty acid signaling molecule cis-2-Decenoic Acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl Environ Microbiol 80:6976-6991.
62. Möker N, Dean CR, Tao J. 2010. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192:1946-1955.
63. Moyed HS, Bertrand KP. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155:768-775.
64. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192:6191-6199.
65. Orman MA, Brynildsen MP. 2013. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57:3230-3239.
66. Osbourne DO, Soo VWC, Konieczny I, Wood TK. 2014. Polyphosphate, cyclic AMP, guanosine tetraphosphate, and c-di-GMP reduce in vitro Lon activity. Bioengineered 5:264-268.
67. Pan J, Bahar AA, Syed H, Ren D. 2012. Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS ONE 7:e45778.
68. Pan J, Song F, Ren D. 2013. Controlling persister cells of Pseudomonas aeruginosa PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. Bioorg Med Chem Lett 23:4648-4651.
69. Pecota DC, Wood TK. 1996. Exclusion of T4 phage by the hok/sok killer locus from plasmid R1. J Bacteriol 178:2044-2050.
70. Prysak MH, Mozdzierz CJ, Cook AM, Zhu L, Zhang Y, Inouye M, Woychik NA. 2009. Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol Microbiol 71:1071-1087.
71. Rasko DA, Sperandio V. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9:117-128.
72. Ren D, Bedzyk LA, Thomas SM, Ye RW, Wood TK. 2004. Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol 64:515-524.
73. Schmidt NW, Deshayes S, Hawker S, Blacker A, Kasko AM, Wong GCL. 2014. Engineering persister-specific antibiotics with synergistic antimicrobial functions. ACS Nano 8:8786-8793.
74. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, Brennan RG. 2009. Molecular mechanisms of HipA mediated multidrug tolerance and its neutralization by HipB. Science 323:396-401.
75. Schumacher MA, Balani P, Min J, Chinnam NB, Hansen S, Vulic M, Lewis K, Brennan RG. 2015. HipBA-promoter structures reveal the basis of heritable multidrug tolerance. Nature 524:59-64.
76. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006. Persisters: A distinct physiological state of E. coli. BMC Microbiol 6:53.
77. Shan Y, Lazinski D, Rowe S, Camilli A, Lewis K. 2015. Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. mBio 6:e00078-e00015.
78. Sharma B, Brown AV, Matluck NE, Hu LT, Lewis K. 2015. Borrelia burgdorferi, the causative agent of Lyme disease, forms drug-tolerant persister cells. Antimicrob Agents Chemother 59:4616-4624.
79. Shi W, Zhang X, Jiang X, Yuan H, Lee JS, Barry CE, Wang H, Zhang W, Zhang Y. 2011. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 333:1630-1632.
80. Shields CL, Naseripour M, Shields JA. 2002. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133:601-606.
81. Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H, Takeda K. 2013. Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS ONE 8:e80604.
82. Starkey M, Lepine F, Maura D, Bandyopadhaya A, Lesic B, He J, Kitao T, Righi V, Milot S, Tzika A, Rahme L. 2014. Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog 10:e1004321.
83. Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199-210.
84. Vega NM, Allison KR, Khalil AS, Collins JJ. 2012. Signaling-mediated bacterial persister formation. Nat Chem Biol 8:431-433.
85. Wakamoto Y, Dhar N, Chait R, Schneider K, Signorino-Gelo F, Leibler S, McKinney JD. 2013. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339:91-95.
86. Wang D, Ding X, Rather PN. 2001. Indole can act as an extracellular signal in Escherichia coli. J Bacteriol 183:4210-4216.
87. Wang X, Kim Y, Hong SH, Ma Q, Brown BL, Pu M, Tarone AM, Benedik MJ, Peti W, Page R, Wood TK. 2011. Antitoxin MqsA helps mediate the bacterial general stress response. Nat Chem Biol 7:359-366.
88. Wang X, Lord DM, Cheng H-Y, Osbourne DO, Hong SH, Sanchez-Torres V, Quiroga C, Zheng K, Herrmann T, Peti W, Benedik MJ, Page R, Wood TK. 2012. A Novel type V TA system where mRNA for toxin GhoT is cleaved by antitoxin GhoS. Nat Chem Biol 8:855-861.
89. Wang X, Wood TK. 2011. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol 77:5577-5583.
90. Wood TK, Knabel SJ, Kwan BW. 2013. Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79:7116-7121.